Search
Indivior PLC
INDVAdd to Watchlist
40.010USD
-0.210-0.52%
Close 07-31 16:00（ET）Quotes delayed by 15 min
4.88BMarket Cap
23.82P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Indivior PLC is 8.67, ranking 12 out of 155 in the Pharmaceuticals industry. The average price target is 36.00, with a high of 41.00 and a low of 35.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
49.167
Target Price
+22.61%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Indivior PLC
INDV
6
Amgen Inc
AMGN
37
Biogen Inc
BIIB
37
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Indivior PLC's expected revenue for the next quarter?
Indivior PLC's expected revenue is 307.55M.
What is Indivior PLC's price target?
Analysts forecast that Indivior PLC's price target is USD 36.00, with the highest forecast at USD 41.00 and the lowest forecast at USD 35.00.
How have Indivior PLCINDV's recent earnings per share performed?
The market expectation was USD 0.72, while Indivior PLCINDV's earnings per share (EPS) for the previous quarter was USD 0.82. EPS for the next quarter is expected at USD 0.87.
What is the analyst rating for Indivior PLC?
Based on the ratings of Indivior PLC's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.